364 related articles for article (PubMed ID: 9712077)
21. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection.
Blank M; Shani A; Goldberg I; Kopolovic J; Amigo MC; Magrini L; Shoenfeld Y
Thromb Res; 2004; 114(5-6):589-92. PubMed ID: 15507295
[TBL] [Abstract][Full Text] [Related]
22. Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies.
Arvieux J; Regnault V; Hachulla E; Darnige L; Berthou F; Youinou P
Thromb Haemost; 2001 Oct; 86(4):1070-6. PubMed ID: 11686326
[TBL] [Abstract][Full Text] [Related]
23. Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display.
Chukwuocha RU; Hsiao ET; Shaw P; Witztum JL; Chen PP
J Immunol; 1999 Oct; 163(8):4604-11. PubMed ID: 10510405
[TBL] [Abstract][Full Text] [Related]
24. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.
Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y
Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701
[TBL] [Abstract][Full Text] [Related]
25. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
[TBL] [Abstract][Full Text] [Related]
26. Detection and characterization of B cell epitopes on beta2-glycoprotein I.
Cockerill KA; Linnik MD; Iverson GM
Clin Immunol; 2004 Aug; 112(2):129-35. PubMed ID: 15240155
[TBL] [Abstract][Full Text] [Related]
27. Avidity of anti-beta-2-glycoprotein I antibodies.
Bozic B; Cucnik S; Kveder T; Rozman B
Autoimmun Rev; 2005 Jun; 4(5):303-8. PubMed ID: 15990078
[TBL] [Abstract][Full Text] [Related]
28. Binding of high-avidity anti-beta2-glycoprotein I antibodies.
Cucnik S; Kveder T; Rozman B; Bozic B
Rheumatology (Oxford); 2004 Nov; 43(11):1353-6. PubMed ID: 15280573
[TBL] [Abstract][Full Text] [Related]
29. Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies.
Kouts S; Wang MX; Adelstein S; Krilis SA
J Immunol; 1995 Jul; 155(2):958-66. PubMed ID: 7608571
[TBL] [Abstract][Full Text] [Related]
30. Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies.
d'Angeac AD; Stefas I; Duperray C; Rucheton M; Graafland H; Montero JL; Chicheportiche R
J Immunol Methods; 2005 May; 300(1-2):160-78. PubMed ID: 15904931
[TBL] [Abstract][Full Text] [Related]
31. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
32. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
33. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
35. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
36. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.
Wang MX; Kandiah DA; Ichikawa K; Khamashta M; Hughes G; Koike T; Roubey R; Krilis SA
J Immunol; 1995 Aug; 155(3):1629-36. PubMed ID: 7543528
[TBL] [Abstract][Full Text] [Related]
37. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.
Blank M; George J; Barak V; Tincani A; Koike T; Shoenfeld Y
J Immunol; 1998 Nov; 161(10):5303-12. PubMed ID: 9820503
[TBL] [Abstract][Full Text] [Related]
38. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
[TBL] [Abstract][Full Text] [Related]
39. Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I?
Gharavi AE; Harris EN; Sammaritano LR; Pierangeli SS; Wen J
J Lab Clin Med; 1993 Oct; 122(4):426-31. PubMed ID: 8228557
[TBL] [Abstract][Full Text] [Related]
40. Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources.
Reddel SW; Wang YX; Sheng YH; Krilis SA
J Autoimmun; 2000 Sep; 15(2):91-6. PubMed ID: 10968891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
